FrancophonIA/ELRC3.0 huggingface dataset:
English: 1.8 ml containing 0.90 mg fentanyl ensuring the delivery of 10 doses of 50 micrograms 2.9 ml containing 1.45 mg fentanyl ensuring the delivery of 20 doses of 50 micrograms 5.0 ml containing 2.50 mg fentanyl ensuring the delivery of 40 doses of 50 micrograms
Maltese: Instanyl 50 mikrogrammi/sprej iddożat għall-imnieħer, soluzzjoni 1.8 ml li fiha 0.90 mg fentanyl li tiżgura l-forniment ta' 10 dożi ta' 50 mikrogramma 2.9 ml li fiha 1.45 mg fentanyl li tiżgura l-forniment ta' 20 doża ta' 50 mikrogramma 5.0 ml li fiha 2.50 mg fentanyl li tiżgura l-forniment ta' 40 doża ta' 50 mikrogramma
English: Instanyl 50 micrograms nasal spray, solution in single-dose container Instanyl 100 micrograms nasal spray, solution in single-dose container Instanyl 200 micrograms nasal spray, solution in single-dose container fentanyl
Maltese: Instanyl 50 mikrogrammi sprej għall-imnieħer, soluzzjoni, f'kontenitur b'doża waħda Instanyl 100 mikrogrammi sprej għall-imnieħer, soluzzjoni, f'kontenitur b'doża waħda
English: Remove the protective cap from the spray.
Maltese: Neħħi l-għatu protettiv minn fuq l-isprej.
English: 1 dose (100 microlitres) contains fentanyl citrate equivalent to 100 micrograms (mcg) fentanyl
Maltese: Doża waħda (100 mikrolitru) fiha fentanyl citrate ekwivalenti għal 100 mikrogramma (µg) fentanyl
English: Takeda Belgium
Maltese: Takeda, UAB
English: Local tolerance studies with Instanyl in mini-pigs demonstrated that Instanyl administration was well tolerated.
Maltese: Studji ta' tolleranza lokali b'Instanyl fi qżieqeż żgħar urew li l-għoti ta' Instanyl kien tollerat sew.
English: Takeda France S.A.S Tel.: +33 1 46 25 16 16
Maltese: Takeda Pharma sp. z o.o. Tel.: +48 22 608 13 00
English: This leaflet was last revised in {MM/YYYY}.
Maltese: Id-data ta' meta tiskadi tirreferi għall-aħħar jum ta' dak ix-xahar.
English: If Instanyl nasal spray is frozen the spray pump may crack.
Maltese: Kun ċert li l-pompa hija magħfusa kompletament 'l isfel.
English: Limited data on pharmacokinetics, efficacy and safety are available for the use of Instanyl in patients above 65 years of age.
Maltese: Tagħrif limitat fuq il-farmakokinetiċi, l-effikaċja u s-sigurtà huma disponibbli għall-użu f'Instanyl f'pazjenti li għandhom iktar minn 65 sena t'età.
English: Instanyl 50 micrograms/dose nasal spray, solution
Maltese: Instanyl 50 mikrogramma/sprej iddożat għall-imnieħer, soluzzjoni
English: The nasal spray is empty when the display shows ‘0' and the lock symbol appears.
Maltese: L-isprej nażali jkun vojt meta d-display turi "0" u s-simbolu tal-katnazz jidher.
English: 1 puff (100 microlitres) contains 50 micrograms fentanyl.
Maltese: Nefħa waħda (100 mikrolitru) fiha 50 mikrogramma fentanyl.
English: In a fertility and early embryonic development study in rats, a male-mediated effect was observed at high doses (300 µg/kg/day, s.c.) and is consistent with the sedative effects of fentanyl in animal studies.
Maltese: Fi studju dwar il-fertilità u l-iżvilupp embrijoniku bikri fil-firien, effett fuq l-irġiel ġie osservat f'dożi għoljin (300 μg/kg/jum, s.c.) u hu konsistenti mal-effetti sedattivi ta' fentanyl fi studji fuq l-annimali.
English: 1 puff (100 microlitres) contains 100 micrograms fentanyl.
Maltese: Nefħa waħda (100 mikrolitru) fiha 100 mikrogramma fentanyl.
English: EU/1/09/531/014 EU/1/09/531/015 EU/1/09/531/016 EU/1/09/531/017
Maltese: EU/1/09/531/016 EU/1/09/531/017
English: NAME OF THE MEDICINAL PRODUCT Instanyl 200 micrograms/dose nasal spray, solution Fentanyl
Maltese: Instanyl 200 mikrogramma/sprej iddożat għall-imnieħer, soluzzjoni DoseGuard
English: No distinct correlation between the maintenance opioid dose and Instanyl doses have been established, however in the second pivotal study patients receiving low maintenance opioid dose tended to achieve effective pain relief with a lower strength of Instanyl compared to patients taking higher levels of maintenance opioid dose.
Maltese: Uġigħ qawwi f'daqqa huwa uġigħ addizzjonali li jiġi f'daqqa minkejja li tkun ħadt l opiojdi tas-soltu biex itaffu l-uġigħ.
English: The initial strength should be one dose of 50 micrograms in one nostril, titrating upwards as necessary through the range of available strengths (50, 100, and 200 micrograms).
Maltese: Metodu ta' tittrazzjoni Il-qawwa inizjali għandha tkun ta' ta' doża waħda ta' 50 mikrogramma f'kull minfes, li tiġi ttittrata 'l fuq kif meħtieġ permezz tal-firxa ta' qawwiet disponibbli (50, 100, u 200 mikrogramma).
English: 1.8 ml containing 1.80 mg fentanyl ensuring the delivery of 10 doses of 100 micrograms 2.9 ml containing 2.90 mg fentanyl ensuring the delivery of 20 doses of 100 micrograms 5.0 ml containing 5.00 mg fentanyl ensuring the delivery of 40 doses of 100 micrograms
Maltese: Instanyl 100 mikrogramma/sprej iddożat għall-imnieħer, soluzzjoni 1.8 ml li fiha 1.80 mg fentanyl li tiżgura l-forniment ta' 10 dożi ta' 100 mikrogramma 2.9 ml li fiha 2.90 mg fentanyl li tiżgura l-forniment ta' 20 doża ta' 100 mikrogramma 5.0 ml li fiha 5.00 mg fentanyl li tiżgura l-forniment ta' 40 doża ta' 100 microgramma
English: The concomitant use of partial opioid agonists/antagonists (e.g. buprenorphine, nalbuphine, pentazocine) is not recommended.
Maltese: L-użu fl-istess ħin ta' agonisti/antagonisti ta' opiojdi parzjali (eż. buprenorphine, nalbuphine, pentazocine) mhux rakkomandat.
English: Fentanyl is an opioid analgesic interacting primarily with the opioid μ-receptor as a pure agonist with low affinity for the - and κ-opioid receptors.
Maltese: Studji aktar riċenti wrew li effetti fuq l-embrijo kienu dovuti għal tossiċità maternali u mhux għal effetti diretti tas-sustanzi tal-embriju li qed jiżviluppa.
English: Patients should wait 4 hours before treating another breakthrough pain episode with Instanyl during both titration and maintenance therapy.
Maltese: Il-pazjenti għandhom jistennew 4 sigħat qabel ma jerġgħu jittrattaw episodju ieħor ta' uġigħ qawwi li jiġi f'daqqa b'Instanyl kemm għal tittrazzjoni u għal terapija ta' manteniment.
English: You will hear a ‘click' sound when the pump is pressed down completely and the nasal spray has delivered the dose.
Maltese: Se tisma' ħoss ta' "klikk" meta l-pompa tkun magħfusa 'l isfel kompletament, u l-isprej nażali jkun ipprovda d-doża.
English: They have high affinity to opioid receptors with relatively low intrinsic activity and therefore partially antagonise the analgesic effect of fentanyl and may induce withdrawal symptoms in opioid dependent patients.
Maltese: Huma għandhom affinità għolja għal riċettaturi tal-opijojdi b'attività intrinsika relattivament baxxa u għalhekk parzjalment jantagonizzaw l-effett anaġeżiku ta' fentanyl, u jistgħu jinduċu sintomi ta' nuqqas ta' teħid tal-prodott f'pazjenti dipendenti fuq opijojdi.
English: Hyperhidrosis
Maltese: Tfal u adolexxenti
English: A pharmacokinetic study has shown that Instanyl single-dose and multi-dose nasal spray are bioequivalent.
Maltese: Studju farmakokinetiku wera li l-isprej ta' Instanyl ta' doża waħda u ta' multidożi huma bijoekwivalenti.
English: Hypotension
Maltese: Vertiġini
English: Please consider to contact the physician for discussion.
Maltese: Jekk jogħġbok fittex għajnuna medika immedjata.
English: Each black mark equals 10 minutes; the maximum locking period is 2 hours.
Maltese: Kull marka sewda tfisser 10 minuti; il-perjodu massimu li fih it-tagħmir ikun imsakka hu ta' sagħtejn.
English: 1 dose of 100 microlitres equals 100 micrograms fentanyl.
Maltese: 100 mikrogramma fentanyl.
English: 1 dose (100 microlitres) contains fentanyl citrate equivalent to 50 micrograms (mcg) fentanyl
Maltese: Doża waħda (100 mikrolitru) fiha fentanyl citrate ekwivalenti għal 50 mikrogramma (µg) fentanyl.
English: Preparing the Instanyl nasal spray
Maltese: Jekk tinsa tuża Instanyl
English: NAME OF THE MEDICINAL PRODUCT Instanyl 100 micrograms/dose nasal spray, solution Fentanyl
Maltese: Instanyl 100 mikrogramma/sprej iddożat għall-imnieħer, soluzzjoni DoseGuard
English: Instanyl 100 micrograms/dose nasal spray, solution
Maltese: Instanyl 100 mikrogramma/sprej iddożat għall-imnieħer, soluzzjoni
English: Subjects with allergic rhinitis received oxymetazoline nasal spray one hour prior to Instanyl.
Maltese: prodotti mediċinali li jdgħajfu l-metaboliżmu tas-serotonin (inklużi l-Inibituri tal-Monoamine Oxidase [MAOIs]).
English: Nasal spray, solution 1.8 ml Nasal spray, solution 2.9 ml Nasal spray, solution 5.0 ml
Maltese: U KONTENUT Sprej għall-imnieħer, soluzzjoni 1.8 ml
English: - medicines called partial agonist/antagonists e.g. buprenorphine, nalbuphine and pentazocine (medicines for treatment of pain).
Maltese: L-UŻU Prodott mediċinali li jingħata b'riċetta speċjali u ristretta tat-tabib (Ara Anness I: Sommarju tal- Karatteristiċi tal-Prodott, sezzjoni 4.2).
English: NAME OF THE MEDICINAL PRODUCT Instanyl 50 micrograms/dose nasal spray, solution Fentanyl
Maltese: Instanyl 50 mikrogrammi/sprej iddożat għall-imnieħer, soluzzjoni.DoseGuard
English: B. PACKAGE LEAFLET
Maltese: PAKKETT TAL-FOLJA REŻISTENTI
English: Start at 50 micrograms
Maltese: 50 mikrogrammi sa 400 mikrogramma Instanyl.
English: NAME OF THE MEDICINAL PRODUCT Instanyl 200 micrograms nasal spray, solution in single-dose container Fentanyl
Maltese: Instanyl 200 mikrogramma sprej tal-imnieħer, soluzzjoni f'kontenitur b'doża waħda fentanyl
English: 1 dose of 100 microlitres equals 50 micrograms fentanyl.
Maltese: Doża waħda ta' 100 mikrolitru hi ugwali għal 50 mikrogramma fentanyl.
English: 1 dose of 100 microlitres equals 200 micrograms fentanyl.
Maltese: Doża waħda ta' 100 mikrolitru hi ugwali għal 200 mikrogramma fentanyl.
English: Bottle (brown Type 1 glass) with metering pump and dust cap packed in a child-resistant outer box.
Maltese: Flixkun (ħġieġ kannella Tip 1) b'pompa tal-kejl u b'għatu għal kontra t-trab f'kaxxa ta' barra reżistenti għal ftuħ mit-tfal.
English: Some changes that can be seen include an increase in serum prolactin, and decreases in plasma cortisol and testosterone.
Maltese: Xi bidliet li jistgħu jiġu osservati jinkludu żieda tal-prolactin fis-serum, u tnaqqis ta' cortisol u testosterone fil-plażma.
English: The Instanyl nasal spray has:
Maltese: Il-kontenut hu:
English: NAME OF THE MEDICINAL PRODUCT Instanyl 50 micrograms nasal spray, solution in single-dose container Fentanyl
Maltese: U KWANTITATTIVA Instanyl 50 mikrogrammi sprej għall-imnieħer, soluzzjoni, f'kontenitur b'doża waħda
English: In clinical trials elderly patients tend to titrate to a lower effective strength than patients less than 65 years of age.
Maltese: Fi provi kliniċi pazjenti anzjani għandhom tendenza li d-doża effettiva f'tittrazzjoni hija inqas minn dik ta' pazjenti li għadhom m'għalqux 65 sena.
English: Common cold
Maltese: Riħ komuni
English: Impaired renal or hepatic function
Maltese: koxjenza indebolita jew koma.
English: Fentanyl is highly lipophilic.
Maltese: Fi studji fuq l-annimali,
English: Typical opioid adverse reactions are to be expected with Instanyl.
Maltese: Reazzjonijiet avversi tipiċi għal opijojdi huma mistennija b'Instanyl.
English: - other medicines taken via the nose, especially oxymetazoline, xylometazoline and similar medicines, which are used for relief of nose congestions.
Maltese: - mediċini oħra li jittieħdu mill-imnieħer, speċjalment oxymetazoline, xylometazoline u mediċini simili, li jintużaw għal serħan minn konġestjoni nażali.
English: If the display shows a battery symbol, this means that the battery life is about to run out.
Maltese: Jekk id-display turi simbolu ta' batterija, dan ifisser li l-batterija tkun tkun kważi spiċċat.
English: a) Theory and core principles of Gliolan-fluorescence-guided surgery and malignant glioma resection, including methods of eloquent sites identification; b) On-site instructions on the use of the fluorescence-microscope, including pitfalls and recognition of problems; c) Differentiation of fluorescence intensity, maintaining safety distances from eloquent areas, etc. d) The practice of Gliolan-fluorescence-guided surgery (including participation in at least one cases using Gliolan-fluorescence-guided surgery in the operating room with on-site instructions on the use of the microscope or demonstration of a fluorescence-guided resection by video); e) The current understanding of the benefits and risks of cytoreductive surgery in the management of patients with malignant gliomas; f) The theoretical base for porphyrin accumulation in malignant gliomas; g) The technical principles behind fluorescence-guided resections using Gliolan; h) How to identify suitable candidates for fluorescence-guided resections using Gliolan; i) How to apply Gliolan in the correct dosage and timing regimen, and to understand the importance of concurrent corticosteroids; j) How to identify patients at risk for neurological deficits using fluorescence-guided resections with Gliolan with special focus on aphasias and other critical focal deficits; k) Techniques for intraoperative risk reduction (microsurgical technique, neurophysiological monitoring, choice of approach) and how to implement them; l) How to identify fluorescence for resection through using the operating microscope in a handson setting in the operating room; m) The benefits and risks of fluorescence-guided resections using Gliolan;
Maltese: Il-bażi teoretika għall-akkumulazzjoni ta' porphyrin fi glijomi malinni; g) Il-prinċipji tekniċi wara r-risezzjonijiet iggwidati bil-fluworexxenza li jużaw Gliolan; h) Kif għandhom jiġu identifikati kandidati xierqa għar-risezzjonijiet iggwidati bilfluworexxenza li jużaw Gliolan; i) Kif għandu jiġi applikat Gliolan fid-dożaġġ korrett u reġimen ta' żmien, u kif għandha tiġi mifhuma l-importanza ta' kortikosterojdi li jkunu preżenti fl-istess ħin; j) Kif għandhom jiġu identifikati pazjenti b'riskju ta' defiċit newroloġiku li jużaw risezzjonijiet iggwidati bil-fluworexxenza li jużaw Gliolan b'fokus speċjali fuq afasji u defiċit fokali kritiku ieħor; k) Tekniki għat-tnaqqis inter-operattiv tar-riskji (teknika tal-mikro-kirurġija, monitoraġġ newrofiżjoloġiku, għażla tal-metodu) u kif dawn għandhom jiġu implimentati;
English: III trial; - Experience with Gliolan-fluorescence-guided surgery in at least 20 cases.
Maltese: III; - Esperjenza b'kirurġija ggwidata bil-fluworexxenza ta' Gliolan f'għallinqas 20 każ.
English: IV); - Neurophysiological monitoring techniques for surgery in eloquent brain regions.
Maltese: WHO); - Tekniki ta' monitoraġġ newrofiżjoloġiċi għall-kirurġija f'oqsma tal-moħħ elokwenti.
English: Minimum requirements for a qualified trainer are: - Board-certification as neurosurgeon according to local, national requirements; - Previous successful participation at a training course, or equivalent course during the phase
Maltese: - Ċertifikazzjoni mill-bord bħala newrokirurgu skond ir-rekwiżiti lokali, nazzjonali; - Parteċipazzjoni preċedenti b'suċċess f'kors ta' taħriġ, jew kors ekwivalenti matul il-prova ta' fażi
English: Minimum requirements for a qualified training centre are: - Microscope modified for fluorescence-guided resection; - Sufficient case load (at least 10 patients per year) of malignant gliomas (WHO grade III and
Maltese: - Ammont adegwat ta' pazjenti (għallinqas 10 kull sena) ta' glijomi malinni (grad III u IV ta'
English: This course shall consist of measures aiming to minimise adverse events associated with the Gliolan-fluorescence-guided surgery (in particular neurological serious adverse events) through adequate education about:
Maltese: Dan il-kors għandu jkun magħmul minn miżuri li jimmiraw li jnaqqsu l-avvenimenti avversi assoċjati mal-kirurġija ggwidata bil-fluworexxenza ta' Gliolan (b'mod partikolari avvenimenti avversi newroloġiċi serji) permezz ta' edukazzjoni adegwata dwar:
English: Ziagen abacavir
Maltese: Ziagen abakavir
English: The full EPAR for Ziagen can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It is available as tablets (300 mg) and as an oral solution (20 mg/ml).
Maltese: Jiġi bħala pilloli (300 mg) u bħala soluzzjoni orali (20 mg/ml).
English: The active substance in Ziagen, abacavir, is a nucleoside reverse transcriptase inhibitor (NRTI).
Maltese: Is-sustanza attiva f'Ziagen, l-abakavir, hija inibitur nukleosidiku tat-transkrittażi inversa (nucleoside reverse transcriptase inhibitor - (NRTI)).
English: Other information about Ziagen:
Maltese: Aktar informazzjoni dwar Ziagen:
English: This document is a summary of the European Public Assessment Report (EPAR) for Ziagen.
Maltese: Dan id-dokument huwa sommarju tar-Rapport Pubbliku Ewropew ta' Valutazzjoni (EPAR) għal Ziagen.
English: The recommended dose of Ziagen for adults and children weighing at least 25 kg is 600 mg daily.
Maltese: Id-doża rakkomandata ta' Ziagen għall-adulti u t-tfal li jiżnu mill-inqas 25 kg hija ta' 600 mg kuljum.
English: In one of the studies in adults, 77% of the patients taking Ziagen with lamivudine and zidovudine had viral loads below 400 copies/ml after 16 weeks (67 out of 87), compared with 38% of the adults taking lamivudine and zidovudine without Ziagen (33 out of 86).
Maltese: Ziagen flimkien mal-lamivudina u ż-żidovudina kellhom tagħbijiet virali ta' inqas minn 400 kopja/ml wara 16-il ġimgħa (67 minn 87), meta mqabbla ma' 38% tal-adulti kkurati bil-lamivudina u ż-żidovudina mingħajr Ziagen (33 minn 86).
English: Ziagen has been studied in six main studies including 1,843 HIV-infected adults (aged 18 years and over).
Maltese: Ziagen ġie eżaminat f'sitt studji ewlenin li fihom ħadu sehem 1,843 adult infettat bl-HIV (minn 18-il sena ‘l fuq).
English: Symptoms almost always include fever or rash, but also very commonly include nausea, vomiting, diarrhoea, abdominal pain (stomach ache), dyspnoea (difficulty breathing), cough, fever, lethargy, malaise (feeling unwell), headache, signs of liver damage in the blood and myalgia (muscle pain).
Maltese: Is-sintomi kważi dejjem jinkludu deni jew raxx, iżda anki spiss jinkludu nawżja, remettar, dijarea, uġigħ addominali (uġigħ ta' stonku), dispnea (diffikultà fit-teħid tan-nifs), sogħla, deni, letarġija, telqa (tħossok ma tiflaħx), uġigħ ta' ras, sinjali ta' ħsara tal-fwied fid-demm u mijalġija (uġigħ fil-muskoli).
English: Ziagen is used in combination with other antiviral medicines to treat patients who are infected with human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS).
Maltese: Ziagen jintuża flimkien ma' mediċini antivirali oħra fil-kura ta' pazjenti infettati bil-vajrus talimmunodefiċjenza umana (HIV), il-vajrus li jikkawża s-sindromu tal-immunodefiċjenza akkwiżita (AIDS).
English: The most common side effects with Ziagen (seen in between 1 and 10 patients in 100) are loss of appetite, headache, nausea (feeling sick), vomiting, diarrhoea, rash, fever, lethargy (lack of energy) and tiredness.
Maltese: L-effetti sekondarji l-aktar komuni b'Ziagen (li dehru f'bejn pazjent 1 u 10 minn 100) huma telf ta' aptit, uġigħ ta' ras, nawżja (dardir), remettar, dijarea, raxx, deni, letarġija (nuqqas ta' enerġija) u għeja.
English: What is Ziagen?
Maltese: X'inhu Ziagen?
English: Why has Ziagen been approved?
Maltese: Għaliex ġie approvat Ziagen?
English: Ziagen has also been studied in three main studies including 489 HIV-infected patients aged between three months and 18 years.
Maltese: Ziagen ġie eżaminat ukoll fi tliet studji ewlenin li fihom ħadu sehem 489 pazjent infettati bl-HIV fl-età ta' bejn it-tliet xhur u t-18-il sena.
English: One study compared the effects of Ziagen taken once and twice a day, in combination with lamivudine and efavirenz (other antiviral medicines) in 784 patients.
Maltese: Studju wieħed qabbel l-effetti ta' Ziagen meħud darba u darbtejn kuljum, flimkien ma' lamivudina u efavirenz (mediċini antivirali oħra) f'784 pazjent.
English: What is the risk associated with Ziagen?
Maltese: X'inhu r-riskju assoċjat ma' Ziagen?
English: In addition, the company that markets Ziagen provides educational materials for doctors about hypersensitivity reactions with the medicine, including the need to test patients for the HLA-B (type 5701) gene and to remind patients to contact their doctor immediately if they develop symptoms suggestive of hypersensitivity.
Maltese: Barra minn hekk, il-kumpanija li tqiegħed Ziagen fis-suq tipprovdi materjali edukattivi għat-tobba dwar reazzjonijiet ta' ipersensittività bil-mediċina, inkluż il-ħtieġa li l-pazjenti jiġu eżaminati għall-ġene HLAB (tip 5701) u biex tfakkar lill-pazjenti sabiex jikkuntattjaw lit-tabib tagħhom minnufih jekk jiżviluppaw sintomi li juru ipersensittività.
English: The main measures of effectiveness were the levels of HIV in the blood (viral load) and the number of CD4 T-cells in the blood (CD4 cell count).
Maltese: Il-kejl ewlieni tal-effikaċja kien il-livelli ta' HIV fid-demm (tagħbija virali) u n-numru ta' ċelloli -CD4 T fid-demm (għadd ta' ċelloli CD4).
English: Patients receiving Ziagen also had increases in their CD4 cell counts.
Maltese: Il-pazjenti kkurati b'Ziagen ukoll kellhom żidiet fl-għadd ta' ċelloli CD4.
English: Once- and twice-daily Ziagen had similar effects on viral load.
Maltese: Ziagen darba jew darbtejn kuljum għandu effetti simili fuq tagħbija virali.
English: Ziagen is a medicine that contains the active substance abacavir.
Maltese: Ziagen huwa mediċina li fiha s-sustanza attiva l-abakavir.
English: How has Ziagen been studied?
Maltese: Kif ġie studjat Ziagen?
English: It was more effective than placebo, and was as effective as other antiviral medicines in reducing viral loads in all age groups.
Maltese: Kien iktar effettiv mill-plaċebo, u kien effettiv daqs mediċini antivirali oħra fittnaqqis tat-tagħbijiet virali fil-gruppi tal-etajiet kollha.
English: In children weighing less than 25 kg the recommended dose depends on body weight.
Maltese: Fi tfal li jiżnu inqas minn 25 kg, id-doża rakkomandata tiddependi mill-piż tal-ġisem.
English: Ziagen, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Maltese: Ziagen, meħud f'kombinazzjoni ma' mediċini antivirali oħra, inaqqas lammont ta' HIV fid-demm u jżommu f'livell baxx.
English: Ziagen was taken alone, or added to the combination of lamivudine and zidovudine (other antiviral medicines) or the patients' existing HIV treatment.
Maltese: Ziagen ittieħed waħdu, jew flimkien ma' kombinazzjoni tal-lamivudina u ż-żidovudina (mediċini antivirali oħra) jew mal-kura eżistenti tal-HIV tal-pazjent.
English: CD4 T-cells are white blood cells that are important in helping to fight infections, but which are killed by HIV.
Maltese: Iċ-ċelloli-CD4 T huma ċelloli tad-demm bojod li huma importanti filġlieda kontra l-infezzjonijiet, iżda li jinqatlu bl-HIV.
English: For the full list of all side effects and restrictions with Ziagen, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji kollha rrapportati bi Ziagen, ara l-fuljett ta' tagħrif.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Ziagen on 8 July 1999.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Ziagen fit-8 ta' Lulju 1999.
English: A risk management plan has been developed to ensure that Ziagen is used as safely as possible.
Maltese: Ġie żviluppat pjan ta' ġestjoni tar-riskju biex jiġi żgurat li Ziagen jintuża bl-aktar mod sigur possibbli.
English: How does Ziagen work?
Maltese: Għal xiex jintuża Ziagen?
English: 61700 Brno Czech Republic
Maltese: 61700 Brno Ir-Repubblika Ċeka
English: Clopidogrel ratiopharm contains the active ingredient Clopidogrel which belongs to a group of medicines called antiplatelet medicinal products.
Maltese: Clopidogrel ratiopharm fih is-sustanza attiva Clopidogrel li tifforma parti minn grupp ta' mediċini msejħa prodotti mediċinali ta' antiplejtlets.